Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China flag China · Delayed Price · Currency is CNY
12.61
-0.15 (-1.18%)
Sep 11, 2026, 3:04 PM CST

SHE:300122 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
2,1052,6262,7066,3412,6224,308
Trading Asset Securities
--11.53---
Cash & Short-Term Investments
2,1052,6262,7176,3412,6224,308
Cash Growth
-18.07%-3.37%-57.15%141.81%-39.13%199.68%
Accounts Receivable
10,37711,16516,30227,05920,61412,868
Other Receivables
50.49148.1210.977.88.396.87
Receivables
10,42711,31316,31327,06620,62212,874
Inventory
2,4035,00322,2448,9868,0207,385
Prepaid Expenses
1.460.144.919.73-0.59
Other Current Assets
134.6977.16124.31111.37148.53185.63
Total Current Assets
15,07119,01941,40342,51431,41324,754
Property, Plant & Equipment
5,6265,8806,1655,1204,6933,557
Long-Term Investments
289.35289.35295295284.5239
Goodwill
19.2819.2819.2819.2819.2819.28
Other Intangible Assets
552.6574.48346.25317.68352.71342.8
Long-Term Deferred Tax Assets
3,8923,697966.88569.19186.08115.34
Long-Term Deferred Charges
2,2212,0901,8711,088731.97485.04
Other Long-Term Assets
147.23150.07231.11308.42322.5534.91
Total Assets
27,81831,72051,29750,23238,00430,047

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
612.271,2415,82313,1429,8079,178
Accrued Expenses
459.33578.71522.161,6731,2401,090
Short-Term Debt
302.818,59411,9022,6351,785568.86
Current Portion of Long-Term Debt
2,682765.6285.0136.41--
Current Portion of Leases
9.539.211.7710.29.810.25
Current Income Taxes Payable
-6.5386.86434.59347.7933.25
Current Unearned Revenue
47.1983.411.8711.31--
Other Current Liabilities
950.641,125418.82143.8640.1799.62
Total Current Liabilities
5,06412,40418,86118,08613,23011,871
Long-Term Debt
7,1882,9091,242328.08210.64236.41
Long-Term Leases
5.539.5416.6725.3127.7612.24
Long-Term Unearned Revenue
244.04256.05281.68228.27238.34222.2
Long-Term Deferred Tax Liabilities
31.1135.6644.3157.9660.7748.34
Total Liabilities
12,53215,61420,44618,72613,76812,390

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
2,3942,3942,3942,4001,6001,600
Additional Paid-In Capital
210.19210.19197.8847.96207.96207.96
Retained Earnings
12,42713,23628,26229,05822,42815,849
Total Common Equity
15,03115,84030,85431,50624,23617,657
Minority Interest
254.52266.35-2.23---
Shareholders' Equity
15,28616,10630,85131,50624,23617,657
Total Liabilities & Equity
27,81831,72051,29750,23238,00430,047

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
10,18812,28713,2573,0352,033817.76
Net Cash (Debt)
-8,083-9,662-10,5403,305588.943,490
Net Cash Growth
---461.19%-83.13%-
Net Cash Per Share
-3.38-4.04-4.401.380.251.45
Filing Date Shares Outstanding
2,3942,3942,3942,4002,4002,400
Total Common Shares Outstanding
2,3942,3942,3942,4002,4002,400
Working Capital
10,0076,61522,54224,42818,18312,883
Book Value Per Share
6.286.6212.8913.1310.107.36
Tangible Book Value
14,45915,24630,48831,16923,86417,295
Tangible Book Value Per Share
6.046.3712.7412.999.947.21
Buildings
2,9192,8802,8402,5221,7051,042
Machinery
3,6423,6053,3962,5262,0641,369
Construction In Progress
1,4701,5471,5851,2871,8361,825